- Home
- KMDA vs VALU Comparison
KMDA vs VALU Comparison
Compare KMDA & VALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KMDA
- VALU
- Stock Information
- Founded
- KMDA 1990
- VALU 1931
- Country
- KMDA Israel
- VALU United States
- Employees
- KMDA N/A
- VALU N/A
- Industry
- KMDA Biotechnology: Pharmaceutical Preparations
- VALU Investment Managers
- Sector
- KMDA Health Care
- VALU Finance
- Exchange
- KMDA Nasdaq
- VALU Nasdaq
- Market Cap
- KMDA 399.7M
- VALU 384.1M
- IPO Year
- KMDA N/A
- VALU N/A
- Fundamental
- Price
- KMDA $6.85
- VALU $38.01
- Analyst Decision
- KMDA Strong Buy
- VALU
- Analyst Count
- KMDA 3
- VALU 0
- Target Price
- KMDA $14.67
- VALU N/A
- AVG Volume (30 Days)
- KMDA 80.5K
- VALU 2.6K
- Earning Date
- KMDA 05-14-2025
- VALU 07-25-2025
- Dividend Yield
- KMDA 2.92%
- VALU 3.42%
- EPS Growth
- KMDA 31.21
- VALU 17.96
- EPS
- KMDA 0.28
- VALU 2.28
- Revenue
- KMDA $167,235,000.00
- VALU $35,695,000.00
- Revenue This Year
- KMDA $14.51
- VALU N/A
- Revenue Next Year
- KMDA $9.31
- VALU N/A
- P/E Ratio
- KMDA $23.98
- VALU $16.46
- Revenue Growth
- KMDA 11.83
- VALU N/A
- 52 Week Low
- KMDA $4.74
- VALU $32.94
- 52 Week High
- KMDA $9.16
- VALU $57.68
- Technical
- Relative Strength Index (RSI)
- KMDA 52.85
- VALU 43.89
- Support Level
- KMDA $6.64
- VALU $37.59
- Resistance Level
- KMDA $6.99
- VALU $38.80
- Average True Range (ATR)
- KMDA 0.17
- VALU 0.59
- MACD
- KMDA -0.02
- VALU -0.15
- Stochastic Oscillator
- KMDA 58.00
- VALU 15.50
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
About VALU Value Line Inc.
Value Line Inc is a U.S based company. It produces investment periodicals based on underlying research and making available copyright data, including ranking system and other information, to third parties under written agreements for use in third-party managed and marketed investment products and for other purposes. The company markets under brands including Value Line, the Value Line logo, The Value Line Investment Survey, Smart Research, Smarter Investing and a trusted name in Investment Research. Its only operating segment being Publishing.